Infectious Disease Rapid Diagnostic Testing Market Revenue, Demand, Share, Size | Global Industry Analysis and Research Report 2027

September 7, 2021

The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.

Market Size – USD 1,480.0 Million in 2019, Market Growth – CAGR of 12.2%, Market trends – Growth in funding for the testing product.

The report provides detailed insights into Infectious Disease Rapid Diagnostic Testing market revenue trends, industry trends, consumer trends, market size, market share, market revenue growth drivers, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in Infectious Disease Rapid Diagnostic Testing market size over the forecast period, 2024–2028. The report includes profiles of major players in the Infectious Disease Rapid Diagnostic Testing market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/269

Global Infectious Disease Rapid Diagnostic Testing market revenue growth is primarily driven by a variety of factors and trends, some of which include rising focus by major companies on product/service expansion into new and untapped domestic and international markets, rising investments in strategic agreements and mergers, and rapidly growing competition in the Infectious Disease Rapid Diagnostic Testing market.

Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Infectious Disease Rapid Diagnostic Testing market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Infectious Disease Rapid Diagnostic Testing market revenue growth to a significant extent over the forecast period.

Top key vendors in Infectious Disease Rapid Diagnostic Testing Market include are:

Key participants include Abbott Laboratories, Danaher Corporation, BGI Group, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Luminex Corporation, bioMérieux S.A., Hologic, Inc., Thermo Fisher Scientific Inc., and Becton, Dickinson, and Company, among others.

For the purpose of this report, Emergen Research has segmented into the global infectious disease rapid diagnostic testing market on the basis of product, technology, disease, end-user, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)
- Platforms
- Assays

Technology Outlook (Revenue, USD Billion; 2017-2027)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Enzyme Immunoassay (EIA)
- Real-Time PCR (q-PCR)
- Lateral Flow Immunoassay (LFIA)
- Others

Disease Outlook (Revenue, USD Billion; 2017-2027)
- Bacterial Infection
  1. CT/NG
  2. HAIs
  3. Tuberculosis
  4. Others
- Viral Infection
  1. Hepatitis
  2. Influenza Virus
  3. HPV
  4. HIV-AIDS
  5. Others
- Others Infections

End-User Outlook (Revenue, USD Billion; 2017-2027)
- Clinics
- Hospital
- Diagnostic Center
- Others

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/infectious-disease-rapid-diagnostic-testing-market

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Infectious Disease Rapid Diagnostic Testing Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Region wise performance of the Infectious Disease Rapid Diagnostic Testing industry

North America Infectious Disease Rapid Diagnostic Testing market revenue growth was relatively higher than that of other regional markets in 2024. North America market revenue is expected to continue to remain dominant over the forecast period, supported majorly by robust presence of major players in countries in the region and expansion of overall economic Infectious Disease Rapid Diagnostic Testing growth strategies and initiatives.

Asia Pacific Infectious Disease Rapid Diagnostic Testing market revenue registered the fastest growth rate in 2024, and this trend is expected to continue over the forecast period. Asia Pacific Infectious Disease Rapid Diagnostic Testing market revenue growth is driven by significant market revenue contribution from China, India, and South Korea. Increasing population, favorable government policies and initiatives, and availability of more advanced technologies, services, and offerings in these countries are some key factors driving Infectious Disease Rapid Diagnostic Testing market revenue growth in Asia Pacific.

Europe Infectious Disease Rapid Diagnostic Testing market revenue is expected to continue to remain steady over the forecast period. This can be attributed to changing Infectious Disease Rapid Diagnostic Testing market trends in countries in other major regions and robust focus on research and development initiatives by major firms in the region with the objective to leverage opportunities and drive Infectious Disease Rapid Diagnostic Testing revenue growth.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

We can customize our reports for our customers, for instance, we can add or remove manufacturers, applications or product types, whatever you need in the report. Ask for it by contacting us@ https://www.emergenresearch.com/request-for-customization/269

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Infectious Disease Rapid Diagnostic Testing industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the Infectious Disease Rapid Diagnostic Testing market across different regions?
Who are the major driving forces expected to decide the fate of the Infectious Disease Rapid Diagnostic Testing industry worldwide?
Who are the prominent market players making a mark in the Infectious Disease Rapid Diagnostic Testing market with their winning strategies?
Which Infectious Disease Rapid Diagnostic Testing industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Infectious Disease Rapid Diagnostic Testing market?

Table of Content

Chapter 1. Methodology & Sources

1.1. Infectious Disease Rapid Diagnostic Testing Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Infectious Disease Rapid Diagnostic Testing Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2024-2028